These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
412 related items for PubMed ID: 22503488
1. A randomized, double-blind, placebo-controlled trial to assess prevention of mood episodes with risperidone long-acting injectable in patients with bipolar I disorder. Vieta E, Montgomery S, Sulaiman AH, Cordoba R, Huberlant B, Martinez L, Schreiner A. Eur Neuropsychopharmacol; 2012 Nov; 22(11):825-35. PubMed ID: 22503488 [Abstract] [Full Text] [Related]
2. Risperidone long-acting injectable monotherapy in the maintenance treatment of bipolar I disorder. Quiroz JA, Yatham LN, Palumbo JM, Karcher K, Kushner S, Kusumakar V. Biol Psychiatry; 2010 Jul 15; 68(2):156-62. PubMed ID: 20227682 [Abstract] [Full Text] [Related]
3. A randomized, double-blind, placebo-controlled study of maintenance treatment with adjunctive risperidone long-acting therapy in patients with bipolar I disorder who relapse frequently. Macfadden W, Alphs L, Haskins JT, Turner N, Turkoz I, Bossie C, Kujawa M, Mahmoud R. Bipolar Disord; 2009 Dec 15; 11(8):827-39. PubMed ID: 19922552 [Abstract] [Full Text] [Related]
4. A comparative study of paliperidone palmitate and risperidone long-acting injectable therapy in schizophrenia. Li H, Rui Q, Ning X, Xu H, Gu N. Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun 01; 35(4):1002-8. PubMed ID: 21315787 [Abstract] [Full Text] [Related]
5. Extended-release quetiapine as monotherapy for the treatment of adults with acute mania: a randomized, double-blind, 3-week trial. Cutler AJ, Datto C, Nordenhem A, Minkwitz M, Acevedo L, Darko D. Clin Ther; 2011 Nov 01; 33(11):1643-58. PubMed ID: 22054797 [Abstract] [Full Text] [Related]
6. Risperidone for the treatment of acute mania in children and adolescents with bipolar disorder: a randomized, double-blind, placebo-controlled study. Haas M, Delbello MP, Pandina G, Kushner S, Van Hove I, Augustyns I, Quiroz J, Kusumakar V. Bipolar Disord; 2009 Nov 01; 11(7):687-700. PubMed ID: 19839994 [Abstract] [Full Text] [Related]
7. Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms. Macfadden W, Adler CM, Turkoz I, Haskins JT, Turner N, Alphs L. BMC Psychiatry; 2011 Oct 28; 11():171. PubMed ID: 22034906 [Abstract] [Full Text] [Related]
8. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Clin Ther; 2008 Dec 28; 30(12):2378-86. PubMed ID: 19167596 [Abstract] [Full Text] [Related]
9. Quetiapine monotherapy for mania associated with bipolar disorder: combined analysis of two international, double-blind, randomised, placebo-controlled studies. Vieta E, Mullen J, Brecher M, Paulsson B, Jones M. Curr Med Res Opin; 2005 Jun 28; 21(6):923-34. PubMed ID: 15969892 [Abstract] [Full Text] [Related]
10. Ziprasidone plus a mood stabilizer in subjects with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind trial. Bowden CL, Vieta E, Ice KS, Schwartz JH, Wang PP, Versavel M. J Clin Psychiatry; 2010 Feb 28; 71(2):130-7. PubMed ID: 20122373 [Abstract] [Full Text] [Related]
11. A 6-month randomized open-label comparison of continuation of oral atypical antipsychotic therapy or switch to long acting injectable risperidone in patients with bipolar disorder. Yatham LN, Fallu A, Binder CE. Acta Psychiatr Scand Suppl; 2007 Feb 28; (434):50-6. PubMed ID: 17688463 [Abstract] [Full Text] [Related]
12. Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety. Sachs GS, Grossman F, Ghaemi SN, Okamoto A, Bowden CL. Am J Psychiatry; 2002 Jul 28; 159(7):1146-54. PubMed ID: 12091192 [Abstract] [Full Text] [Related]
13. Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania. Ouyang WC, Hsu MC, Yeh IN, Kuo CC. Int J Psychiatry Clin Pract; 2012 Sep 28; 16(3):178-88. PubMed ID: 22404731 [Abstract] [Full Text] [Related]
14. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis. Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M. J Clin Psychiatry; 2009 Oct 28; 70(10):1424-31. PubMed ID: 19906346 [Abstract] [Full Text] [Related]
15. Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial. Hirschfeld RM, Keck PE, Kramer M, Karcher K, Canuso C, Eerdekens M, Grossman F. Am J Psychiatry; 2004 Jun 28; 161(6):1057-65. PubMed ID: 15169694 [Abstract] [Full Text] [Related]
16. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety. Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T. J Affect Disord; 2009 Jun 28; 115(3):376-85. PubMed ID: 19042026 [Abstract] [Full Text] [Related]
17. Acute and continuation risperidone monotherapy in mania. Vieta E, Brugué E, Goikolea JM, Sánchez-Moreno J, Reinares M, Comes M, Colom F, Martínez-Arán A, Benabarre A, Torrent C. Hum Psychopharmacol; 2004 Jan 28; 19(1):41-5. PubMed ID: 14716711 [Abstract] [Full Text] [Related]
18. A long-term prospective study on the outcome of bipolar patients treated with long-acting injectable risperidone. Vieta E, Nieto E, Autet A, Rosa AR, Goikolea JM, Cruz N, Bonet P. World J Biol Psychiatry; 2008 Jan 28; 9(3):219-24. PubMed ID: 18609430 [Abstract] [Full Text] [Related]
19. Relative effectiveness of adjunctive risperidone on manic and depressive symptoms in mixed mania. Singh V, Bowden CL, Mintz J. Int Clin Psychopharmacol; 2013 Mar 28; 28(2):91-5. PubMed ID: 23238761 [Abstract] [Full Text] [Related]
20. Randomized, Double-Blind, Placebo-Controlled Trial of Asenapine Maintenance Therapy in Adults With an Acute Manic or Mixed Episode Associated With Bipolar I Disorder. Szegedi A, Durgam S, Mackle M, Yu SY, Wu X, Mathews M, Landbloom RP. Am J Psychiatry; 2018 Jan 01; 175(1):71-79. PubMed ID: 28946761 [Abstract] [Full Text] [Related] Page: [Next] [New Search]